Stockpickr: Check Out These Two Biotechs

Stock quotes in this article: PTIE , ALNY , KG , CYTR , RNAI  

Meanwhile, Bumblebee Biotech offers this analysis of Alnylam Pharmaceuticals (ALNY Quote).

Alnylam -- along with Sirna Therapeutics(RNAI Quote), CytRx(CYTR Quote) and numerous other private firms such as Calando -- is developing the most promising drug treatments based on RNAi since the discovery of recombinant DNA and the founding of Genentech(DNA Quote) in the '70s.

Alnylam is smart enough look [to] elsewhere for its drug delivery technology, and therefore ahead of the game. Inex Pharmaceuticals ... is the drug platform match to Alnylam. In our opinion, Alnylam is the only firm with a potentially workable drug delivery partner. Neither CytRx nor Sirna Therapeutics have known drug delivery partners, which is a critical issue.

[This is a] long-term buy.

Bumblebee also seems to like piggybacking SAC Capital's top biotech picks, including Penwest Pharmaceuticals (PPCO Quote) and Progen Industries (PGLA Quote). You can see all of SAC's top holdings on its Stockpickr portfolio page.

Stockpickr tip of the day: We've greatly expanded the functionality of our search page, and we invite you to try it out.

If you want to find all portfolios related to "biotech," go to the search page and type "bio" into the search field. Doing so will return three pages' worth of portfolios that focus on biotech stocks. If you want to find "SAC Capital," just type "SAC Capital" in there. Or if you want to find House Speaker Nancy Pelosi's portfolio, just type "Nancy Pelosi."

You can also search for other features of the site. To search all occurrences of the CNBC stock-picking contest in the forums, use the pulldown menu to select "Forums" and then search "CNBC." (Incidentally, tonight at 7:40 p.m. EST I will be on CNBC discussing how to use Stockpickr in order to do well in CNBC's Million Dollar Portfolio Challenge.)

To search blogs from all around the Internet (not just Stockpickr), select "Blogs" in the pulldown menu and search, for instance, "Cramer" to see all blogs that mention Jim Cramer. Or, to see any videos from around the Internet that mention Jim, select "Videos" from the pulldown menu and search "Cramer." We index videos from TheStreet.com, CNBC, Bloomberg, Wallstrip and many other sources.

Please note that due to factors including low market capitalization and/or insufficient public float, we consider CytRx, Pain Therapeutics, Penwest Pharmaceuticals and Progen Industries to be small-cap stocks. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.

  • Loading Comments...
  •  
1 2 3
Next >

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
At the time of publication, Altucher and/or his fund had no positions in stocks mentioned, although positions may change at any time.

James Altucher is a managing partner at Formula Capital, an alternative asset management firm that runs several quantitative-based hedge funds as well as a fund of hedge funds. He is also the author of Trade Like a Hedge Fund and Trade Like Warren Buffett. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,464.40 1,110.63 2,176.05 32.79
Oil *
77.81
UP
30.69
UP
4.98
UP
6.87
DOWN
0.38
10 Yr
3.28%
SPDR Gold
116.62
+0.29%
+0.45%
+0.32%
-1.15%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services